Abstract:Jinrui Ji, 1, 2, &ast Xiaoyun Wei, 1, 2, &ast Dongyun Wan, 1, 2, &ast Lei Wu, 1, 2, &ast Guangyao Chen, 1, 3, &ast Hengliang Liu 1, 2, &ast 1 Clinical Medical Department, Faculty of Medicine, Henan University of Traditional Chinese Medicine, Zhengzhou, 450000, People's Republic of China; 2 Department of Cardiology, People's Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, 450000, People's Republic of China; 3 Zhengzhou Institute of Gastroenterology, People's Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, 450000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hengliang Liu, Henan University of Traditional Chinese Medicine, No. 33, Huanghe Road, Jinshui District, Zhengzhou, Henan Province, 450000, People's Republic of China, Tel/Fax +86 0371-67077158, Email Purpose: This study investigated the influence of plasma proprotein convertase subtilisin/kexin 9 (PCSK9) levels on the degree of atherosclerosis and major adverse cardiovascular and cerebrovascular events (MACCE) in older adults with non-alcoholic fatty liver disease. Methods: The degree of atherosclerosis severity was assessed by the standard Gensini score quartile method. According to the degree of atherosclerosis, patients were divided into mild (0– 24 points; n=84), moderate (25– 53 points; n=86), and severe groups (≥ 54 points; n=84) and then categorized as MACCE (n=30) or non-MACCE (n=224) according to 6-month follow-up data. The patients' age, sex, smoking history, medical history, and early morning fasting venous blood, for measuring biochemical indexes, were collected. Clinical data were compared between groups and the relationship between Gensini scores and PCSK9 was evaluated. Results: Compared with the mild group, the moderate and severe groups had higher high-sensitivity C-reactive protein(hs-CRP), PCSK9, triglycerides(TG), low-density lipoprotein cholesterol (LDL-C), and lipoprotein(a)[Lp(a)] levels and lower high-density lipoprotein cholesterol(HDL-C) levels (all P< 0.05). Moreover, PCSK9 positively correlated with Gensini scores (r=0.657, P< 0.01). The MACCE and non-MACCE groups had significantly different ages, statin use, Gensini scores, PCSK9, and LDL-C (all P< 0.05). Multi-factorial Cox risk regression analysis showed the Gensini score (HR=1.018, 95% CI: 1.006~1.029) and PCSK9 (HR=1.147, 95% CI: 1.038~1.287) were independent risk factors for MACCE. Conclusion: The Gensini score and PCSK9 levels can be used as predictive indicators for the degree of illness and occurrence of MACCE in older NAFLD patients. Keywords: older adults, non-alcoholic fatty liver disease, proprotein convertase subtilisin/kexin 9, atherosclerosis, major adverse cardiovascular and cerebrovascular events Between population aging, the obesity epidemic, and the effective control of viral hepatitis, non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide, with increasing clinical complications, economic burden, and impact on the quality and longevity of patients' lives. 1,2 NAFLD is intrinsically linked to metabolic and cardiovascular disease and may be involved in cardiovascular disease pathogenesis by inducing insulin resistance, atherogenic dyslipidemia, and the release of systemic inflammatory mediators, coagulation mediators, and oxidative stressors. 3–5 Major adverse cardiovascular and cerebrovascular events (MACCE) are the leading cause of death in patients with NAFLD, 6,7 especially in older NAFLD patients. The risk of cardiovascular events in this patient subgroup needs to be regularly assessed, even when their body mass index is normal. Detecting MACCE in older NAFLD patients at an early stage and intervening as early as possible is the key to improving their quality of life. 8 Plasma proprotein convertase subtilisin/kexin 9 (PCSK9) is a member of the proprotein convertase family, and its functional changes are involved in the progression of cardiovascular disease and atherosclerosis. 9 Studies have found that higher serum PCSK9 levels are associated with higher Gensini coronary artery lesion scores, more severe atherosclerosis, and a greater risk of MACCE. 10,11 To our knowledge, the relationship between PCSK9 levels and the risk of MACCE in older NAFLD patients is unclear. In this study, we investigated the relationship between serum PCSK9 levels and the degree of atherosclerosis in patients with NAFLD and the predictive -Abstract Truncated-

The Food Compass Score is Negatively Related to the Activity of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Healthy Adults.

Evaluation of lipoprotein-associated Phospholipase A2 in Healthy Chinese Han Adult Serum

Lipoprotein-Associated Phospholipase A2 Activity, Ferritin Levels, Metabolic Syndrome, And 10-Year Cardiovascular And Non-Cardiovascular Mortality: Results From The Bruneck Study

N‐6 Fatty Acids Instead of N‐3 and Saturated Fatty Acids Correlate with Body Fat Distribution from Subcutaneous Adipose Tissue to Visceral Adipose Tissue in Healthy and Overweight Subjects

Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease

Abstract MP39: Plasma Phospholipid Fatty Acid and Coronary Heart Disease Risk

A Significant Inverse Relationship Between Concentrations of Plasma Homocysteine and Phospholipid Docosahexaenoic Acid in Healthy Male Subjects.

The Nutri-Score nutrition label: Associations between the underlying nutritional profile of foods and lipoprotein particle subclass profiles in adults

Relationship Between the Concentrations of Plasma Phospholipid Stearic Acid and Plasma Lipoprotein Lipids in Healthy Men

Lipoprotein-Associated Phospholipase A(2) And Risk Of Coronary Disease, Stroke, And Mortality: Collaborative Analysis Of 32 Prospective Studies

Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study

Plasma Phospholipid Fatty Acids and Coronary Heart Disease Risk: A Matched Case-Control Study Within the Women's Health Initiative Observational Study.

Sex-Dimorphic Association of Plasma Fatty Acids with Cardiovascular Fitness in Young and Middle-Aged General Adults: Subsamples from NHANES 2003–2004

Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease

Associations between red blood cells fatty acids, desaturases indices and metabolism of platelet activating factor in healthy volunteers

Associations between food groups and biomarkers of inflammation: Are some foods groups more protective than others?

The association between dietary patterns and the novel inflammatory markers platelet-activating factor and lipoprotein-associated phospholipase A2: a systematic review

Circulating Very-Long-Chain Saturated Fatty Acids Were Inversely Associated with Cardiovascular Health: A Prospective Cohort Study and Meta-Analysis

Association of circulating fatty acids with cardiovascular disease risk: Analysis of individual-level data in three large prospective cohorts and updated meta-analysis

Predictive Value of Plasma PCSK9 Levels for Degree of Atherosclerosis and Major Adverse Cardiovascular and Cerebrovascular Events in Older Adult Patients with Non-Alcoholic Fatty Liver Disease

Association between the liver fat score (LFS) and cardiovascular diseases in the national health and nutrition examination survey 1999–2016